Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Accounts-Payable" stands at 9.22 Billion United States Dollars as of 06/30/2026, the lowest value since 12/31/2024.
As of the end of Johnson & Johnson's second quarter, the item "Accounts Payable" stands at 9.22 Billion USD. This represents a decrease of -11.83 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.55 percent compared to the value the year prior.
The 1 year change in percent is -2.55.
The 3 year change in percent is -11.68.
The 5 year change in percent is 5.96.
The 10 year change in percent is 52.17.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Accounts Payable | 905,699,262,464.00 |
![]() | AbbVie Inc - Accounts Payable | 399,570,305,024.00 |
![]() | Roche Holding AG - Accounts Payable | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Accounts Payable | 280,205,508,085.11 |
![]() | Novartis AG - Accounts Payable | 255,096,620,580.91 |